FLAVORED COLESTID
Clinical safety rating: caution
Comprehensive clinical and safety monograph for FLAVORED COLESTID (FLAVORED COLESTID).
Colestid (colestipol) is a bile acid sequestrant. It binds bile acids in the intestine, forming an insoluble complex that is excreted in feces. This reduces enterohepatic circulation of bile acids, leading to increased hepatic conversion of cholesterol to bile acids, thereby lowering serum low-density lipoprotein (LDL) cholesterol levels.
| Metabolism | Colestipol is not absorbed systemically; it acts locally in the gastrointestinal tract and is excreted unchanged in feces. |
| Excretion | Primarily fecal as insoluble complex (90-95%); <5% renal as glucuronide conjugate; minimal biliary elimination. |
| Half-life | Not applicable due to non-absorbable resin; systemic absorption is negligible. Terminal half-life not defined. |
| Protein binding | Does not bind to plasma proteins as it is not absorbed. |
| Volume of Distribution | Not applicable; minimal systemic absorption (Vd essentially 0). |
| Bioavailability | Oral bioavailability is <0.05% via absorption; acts locally in GI tract. |
| Onset of Action | LDL reduction begins within 7-10 days after oral administration; maximal effect in 4-6 weeks. |
| Duration of Action | LDL reduction persists for 2-3 weeks after cessation; resin binds bile acids without systemic accumulation. |
| Molecular Weight | 10000 |
5-30 grams orally daily, divided into 2-4 doses, starting at 5 grams once daily and increasing by 5 grams every 4-7 days as tolerated; taken with meals and mixed with at least 4-8 oz of liquid per dose.
| Dosage form | GRANULE |
| Renal impairment | No specific recommendations; use caution in severe renal impairment due to potential accumulation of inactive ingredients. GFR <30 mL/min: consider alternative agents or reduced dose under clinical monitoring. |
| Liver impairment | No specific guidelines for Child-Pugh scores; no expected alterations in pharmacokinetics as drug is not systemically absorbed. Use with caution in severe hepatic impairment due to potential electrolyte disturbances. |
| Pediatric use | Not established for children under 18 years; safety and efficacy not determined. In adolescents (≥18 years) use adult dosing titrated to effect with close monitoring. |
| Geriatric use | Start at low end of dosing range (5 grams once daily); titrate slowly. Monitor for constipation, electrolyte imbalances, and drug interactions. No specific age-based dose adjustments recommended. |
| 1st trimester | No evidence of fetal harm in animal studies; limited human data. Use if benefit outweighs risk. |
| 2nd trimester | No evidence of fetal harm; may reduce absorption of fat-soluble vitamins, potentially affecting fetal development. Supplement vitamins as needed. |
| 3rd trimester | No evidence of harm; theoretical risk of decreased maternal absorption of nutrients and vitamins. Monitor and supplement if necessary. |
Clinical note
Comprehensive clinical and safety monograph for FLAVORED COLESTID (FLAVORED COLESTID).
| Placental transfer | Not expected to cross placenta due to high molecular weight and lack of systemic absorption. |
| Breastfeeding | Not absorbed systemically; considered compatible with breastfeeding. May reduce absorption of maternal nutrients; ensure adequate maternal nutrition and vitamin supplementation. |
■ FDA Black Box Warning
Not applicable (no FDA black box warning).
| Serious Effects |
Hypersensitivity to colestipol or any componentComplete biliary obstructionPhenylketonuria (if product contains aspartame)
| Precautions | Can cause hypertriglyceridemia; caution in patients with pre-existing hypertriglyceridemia. Risk of fat-soluble vitamin deficiency (A, D, E, K) with long-term use. May interfere with absorption of other medications; administer other drugs at least 1 hour before or 4 hours after colestipol. Constipation may worsen hemorrhoids. Use caution in patients with gastrointestinal motility disorders or history of bowel obstruction. |
| Food/Dietary | Take with meals to enhance efficacy. Avoid high-fat meals as they reduce binding capacity. Mix with non-carbonated beverages or soft foods; do not take dry. Can be mixed with orange juice without affecting efficacy. May reduce absorption of fat-soluble vitamins; consider vitamin supplementation if long-term therapy. |
Loading safety data…
| Lactation Rating | L3 - Probably Compatible |
| Teratogenic Risk | Colestid (colestipol) is not systemically absorbed; therefore, no fetal exposure is expected. No teratogenic effects have been reported in animal studies or human data. However, use during pregnancy may impair absorption of fat-soluble vitamins (A, D, E, K), potentially affecting fetal development. Trimester-specific risks: First trimester: theoretical risk of vitamin deficiency. Second and third trimesters: risk of vitamin K deficiency leading to neonatal hemorrhage. Overall, the drug is considered low risk due to lack of systemic absorption. |
| Fetal Monitoring | Monitor maternal levels of fat-soluble vitamins (A, D, E, K) periodically, especially during prolonged use. Assess prothrombin time (PT) and international normalized ratio (INR) to monitor for vitamin K deficiency. In the fetus, consider ultrasound to assess growth and development if vitamin deficiency is suspected. Monitor neonate for signs of bleeding (vitamin K deficiency) if taken near term. |
| Fertility Effects | Colestipol may interfere with absorption of fat-soluble vitamins and nutrients critical for reproductive health, but no direct effects on fertility have been reported. In animal studies, no adverse effects on fertility were observed. However, potential vitamin deficiencies could indirectly affect fertility. |
| Clinical Pearls | Flavored Colestid (colestipol) is a bile acid sequestrant used as adjunctive therapy to diet for reduction of elevated serum total and LDL cholesterol. Administer with meals to maximize binding of bile acids. Mix with liquids (water, juice, milk) or soft foods (applesauce, crushed pineapple). Avoid concurrent administration with other medications; give at least 1 hour before or 4 hours after other oral drugs to reduce interference with absorption. Monitor for constipation, which can be severe; increase fluid intake. May reduce absorption of fat-soluble vitamins (A, D, E, K); consider supplementation in long-term therapy. |
| Patient Advice | Take this medication with meals and plenty of water to prevent constipation. · Mix the powder with at least 3-6 ounces of liquid (water, juice, milk) or soft food (applesauce, crushed pineapple) and drink immediately. · Do not take other medications at the same time; take them at least 1 hour before or 4 hours after colestipol. · Common side effects include constipation, bloating, and gas; increase fiber and fluid intake to help. · Contact your doctor if you have severe stomach pain, rectal bleeding, or signs of vitamin deficiency (unusual bruising, bone pain). · Continued adherence to cholesterol-lowering diet and exercise is essential. |